COO vs TPST · P/E 36, rev $4.09B vs $26.3M cap
The Cooper Companies, Inc (COO) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
TPST does not have a complete income-statement cache yet.
COO currently screens at market cap $14.92B and trailing P/E 36.1. TPST currently screens at market cap $26.3M.
Not investment advice. Open the COO and TPST stock pages for the full models.
Not investment advice.